|
According to the reporter, during an open subcutaneous tissue suturing procedure, approximately 50 sutures experienced breakage at the needle-to-suture attachment site during continuous suturing.The problem was resolved only after sutures from a different batch were used for additional suturing.There was no patient injury.
|
|
D10 concomitant product: cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); cl-923, cl-923 polysorb* 2-0 vio 90cm gs21 x36 (lot#a5e1613y); medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|